Radiation Hormesis in Cancer

2020 ◽  
pp. 95-177
Author(s):  
T. D. Luckey
Keyword(s):  
2020 ◽  
Vol 21 (18) ◽  
pp. 6650
Author(s):  
Usha Kabilan ◽  
Tyson E. Graber ◽  
Tommy Alain ◽  
Dmitry Klokov

Protein synthesis, or mRNA translation, is one of the most energy-consuming functions in cells. Translation of mRNA into proteins is thus highly regulated by and integrated with upstream and downstream signaling pathways, dependent on various transacting proteins and cis-acting elements within the substrate mRNAs. Under conditions of stress, such as exposure to ionizing radiation, regulatory mechanisms reprogram protein synthesis to translate mRNAs encoding proteins that ensure proper cellular responses. Interestingly, beneficial responses to low-dose radiation exposure, known as radiation hormesis, have been described in several models, but the molecular mechanisms behind this phenomenon are largely unknown. In this review, we explore how differences in cellular responses to high- vs. low-dose ionizing radiation are realized through the modulation of molecular pathways with a particular emphasis on the regulation of mRNA translation control.


Dose-Response ◽  
2017 ◽  
Vol 15 (1) ◽  
pp. 155932581769753 ◽  
Author(s):  
Shuji Kojima ◽  
Mitsutoshi Tsukimoto ◽  
Noriko Shimura ◽  
Hironobu Koga ◽  
Akishisa Murata ◽  
...  

There is considerable evidence from experimental studies in animals, as well as from clinical reports, that low-dose radiation hormesis is effective for the treatment of cancer and ulcerative colitis. In this study, we present 3 case reports that support the clinical efficacy of low-dose radiation hormesis in patients with these diseases. First, a patient with prostate cancer who had undergone surgical resection showed a subsequent increase in prostate-specific antigen (PSA). His PSA value started decreasing immediately after the start of repeated low-dose X-ray irradiation treatment and remained low thereafter. Second, a patient with prostate cancer with bone metastasis was treated with repeated low-dose X-ray irradiation. His PSA level decreased to nearly normal within 3 months after starting the treatment and remained at the low level after the end of hormesis treatment. His bone metastasis almost completely disappeared. Third, a patient with ulcerative colitis showed a slow initial response to repeated low-dose irradiation treatment using various modalities, including drinking radon-containing water, but within 8 months, his swelling and bleeding had completely disappeared. After 1 year, the number of bowel movements had become normal. Interest in the use of radiation hormesis in clinical practice is increasing, and we hope that these case reports will encourage further clinical investigations.


Author(s):  
Noelia Castillejo ◽  
Lorena Martínez-Zamora ◽  
Francisco Artés–Hernández
Keyword(s):  

2021 ◽  
Vol 66 (2) ◽  
pp. 36-52
Author(s):  
A. Koterov ◽  
A. Vaynson

The review considers the reasons that do not allow the use of radiation hormesis for public health and for the prevention of diseases in the population. It is noted that evidence of the hormesis effects of low doses radiation with low LET was obtained only in laboratory experiments on cells and animals, using a hypothetical-deductive method and adequate controls. Some confirmation was found in balneology (radon therapy) and in the clinic (immunostimulation in cancer patients). At the same time, in epidemiological, observational studies, which mainly involve the induction method, there are no unambiguous data on hormesis effects on the frequency of carcinogenesis. This is due to the fact that in the region of low doses (up to 0.1 Gy), in addition to linear, any forms of dose dependence are equally probable, and it is impossible to isolate the radiation effect due to the iinfluence of non-radiation factors, as well as confounders and biases. The epidemiological designs used to confirm radiation hormesis in terms of the frequency of malignant neoplasms have such significant drawbacks and limitations for small magnitudes of effects that, according to epidemiology, there is no possibility for conclusions about hormesis. The stated is, among other things, the position of UNSCEAR, ICRP, BEIR and NCRP, which in the relevant documents, however, is presented insufficiently. For many experimental researchers and clinicians (of any rank), who are not familiar with the basics of classical epidemiology and descriptive disciplines, this position remains incomprehensible and incomprehensible. It is concluded that although hormesis may exist at low doses of radiation, it will hardly be possible to prove and, moreover, to use it in epidemiology and medicine for the prevention of a healthy population. At the same time, it is necessary to actively develop the clinical use of radiation in low doses, but only as a therapeutic immunostimulation in severe pathologies.


2007 ◽  
Vol 4 (1) ◽  
pp. 1 ◽  
Author(s):  
Bobby R. Scott ◽  
Munima Haque ◽  
Jennifer Di Palma

Sign in / Sign up

Export Citation Format

Share Document